Literature DB >> 27986132

Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health.

Avrom Caplan1, Nicole Fett2, Misha Rosenbach1, Victoria P Werth1, Robert G Micheletti3.   

Abstract

Systemic glucocorticoids are an essential therapy for a range of conditions, but their multiple side effects can produce significant morbidity for patients. The objective of this review is to discuss these side effects while addressing 3 questions: 1) What dose and duration of glucocorticoid therapy should prompt concern for individual side effects?; 2) How should clinicians counsel patients about these complications?; and 3) How can these problems be prevented or managed? To accomplish these objectives, we have created a series of tables and algorithms based on a review of relevant data to guide counseling, prophylaxis, and management of 11 glucocorticoid side effects. The first article in this 4-part continuing medical education series begins with a review of glucocorticoid pharmacology followed by a discussion of bone health (ie, osteoporosis and osteonecrosis).
Copyright © 2016 American Academy of Dermatology, Inc. All rights reserved.

Entities:  

Keywords:  glucocorticoids; medication monitoring; osteonecrosis; osteoporosis; pharmacology; side effects; steroids

Mesh:

Substances:

Year:  2017        PMID: 27986132     DOI: 10.1016/j.jaad.2016.01.062

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  40 in total

1.  Long-Term Therapy with Corticosteroids in Nasal Polyposis: A Bone Metabolism Assessment.

Authors:  M Gelardi; F Barbara; I Covelli; M A Damiani; F Plantone; A Notarnicola; B Moretti; N Quaranta; G Ciprandi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-08-01

Review 2.  Pemphigus.

Authors:  Michael Kasperkiewicz; Christoph T Ellebrecht; Hayato Takahashi; Jun Yamagami; Detlef Zillikens; Aimee S Payne; Masayuki Amagai
Journal:  Nat Rev Dis Primers       Date:  2017-05-11       Impact factor: 52.329

Review 3.  Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.

Authors:  Pojchong Chotiyarnwong; Eugene V McCloskey
Journal:  Nat Rev Endocrinol       Date:  2020-04-14       Impact factor: 43.330

4.  [Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases].

Authors:  D Freier; C Strehl; F Buttgereit
Journal:  Hautarzt       Date:  2020-02       Impact factor: 0.751

Review 5.  [Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases].

Authors:  D Freier; C Strehl; F Buttgereit
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

6.  Assessment of side effects after serial intralesional steroid injections for idiopathic subglottic stenosis.

Authors:  Ozlem Onerci Celebi; Sungjin A Song; Alena Santeerapharp; Kanittha Choksawad; Ramon A Franco
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-18       Impact factor: 2.503

7.  Proton pump inhibitors' use and risk of hip fracture: a systematic review and meta-analysis.

Authors:  Salman Hussain; Ali Nasir Siddiqui; Anwar Habib; Md Sarfaraj Hussain; Abul Kalam Najmi
Journal:  Rheumatol Int       Date:  2018-08-29       Impact factor: 2.631

8.  Advanced age adversely affects chronic rhinosinusitis surgical outcomes.

Authors:  Kristen L Yancey; Anne S Lowery; Rakesh K Chandra; Naweed I Chowdhury; Justin H Turner
Journal:  Int Forum Allergy Rhinol       Date:  2019-08-27       Impact factor: 3.858

Review 9.  Glucocorticoid treatment in juvenile idiopathic arthritis.

Authors:  Ezgi Deniz Batu
Journal:  Rheumatol Int       Date:  2018-10-01       Impact factor: 2.631

Review 10.  Advances in treatment of glucocorticoid-induced osteoporosis.

Authors:  Emory Hsu; Mark Nanes
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-12       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.